Trial Profile
A Randomized, Multiple-Dose,Double-Blind,Crossover Trial to Assess the Systemic Exposure of Fluticasone Propionate (FP)/Formoterol Fumarate (FF) Fixed-Dose Combination in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Mar 2013
Price :
$35
*
At a glance
- Drugs Formoterol/fluticasone propionate (Primary) ; Fluticasone propionate; Formoterol
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Dey Laboratories
- 25 Sep 2009 Actual patient number (97) added as reported by ClinicalTrials.gov.
- 25 Sep 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
- 25 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.